Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
If you need cash right now, there are several ways to obtain it quickly. Learn about options available to secure immediate funds.
24,959 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
What could Nu Holdings look like a decade from now? This article breaks down growth catalysts, potential paths, and p...
As AeroVironment approaches its March earnings release, a growing chorus of analysts signals meaningful upside, point...
Rocket Companies closed 2025 with $6.7 billion in revenue and rising mortgage activity, alongside strategic deals tha...
Markets opened lower as geopolitical tensions with Iran intensified, sending risk assets lower while energy and defen...
A major institutional move is shaping Balchem's next chapter. As the company posts record sales, a new investor stake...
A wave of commercial real estate loans is set to mature in 2026, testing lenders’ balance sheets and drawing Bitcoin ...
With the USMCA review approaching in 2026, two key signals will shape how investors position in Mexico and related ma...
UniCredit announces a $40 billion bid for Germany’s second-largest bank with a 4% premium, but early signals point to...
When a mining stock slumps, it usually signals a mix of precious metal prices, costs, and market sentiment. This piec...
Three months into 2026, the 2.8% COLA boosted average benefits to $2,071, but a surge in energy prices and Medicare w...
Stocks moved higher after a choppy morning, with broad participation lifting the S&P 500 and SPY. Traders are weighin...